Pharmacology, Toxicology and Pharmaceutical Science
Cross-Sectional Study
100%
Pharmacotherapy
67%
Ustekinumab
67%
Warfarin
50%
Combination Therapy
43%
Anticoagulant Agent
41%
Inflammation
40%
Toll Like Receptor 4
33%
Ubidecarenone
33%
Etanercept
33%
Antiinfective Agent
33%
Chronic Inflammation
33%
Pharmacy Practice
33%
Pharmaceutical Care
33%
Cardiovascular Disease
33%
Heart Infarction
33%
Distress Syndrome
33%
Diet Induced Obesity
33%
Myeloid Differentiation Factor 88
33%
Atrial Fibrillation
33%
Vascular Disease
33%
Metabolic Disorder
33%
Intestine Flora
33%
Microflora
33%
Insulin Resistance
33%
Tumor Necrosis Factor Inhibitor
33%
Comorbidity
31%
Risankizumab
27%
Resveratrol
27%
Medication Error
24%
Adalimumab
20%
Endothelial Dysfunction
20%
Clinical Pharmacy
16%
Bleeding
16%
Rivaroxaban
16%
Disease Duration
16%
Apigenin
16%
Tumor Necrosis Factor
14%
Lipopolysaccharide
13%
Heavy Metal
11%
Diabetes Mellitus
11%
Diseases
10%
Remission
9%
Heart Disease
7%
Protein Ligand
6%
Receptor
6%
Biological Marker
6%
Wistar Rat
6%
Ixekizumab
6%
Therapeutic Effect
6%
Medicine and Dentistry
Combination Therapy
43%
Cross Sectional Study
40%
Cardiovascular System
33%
Metabolic Disorder
33%
Water-Electrolyte Imbalance
33%
Chronic Inflammation
33%
Chronic Disease
33%
Antiinfective Agent
33%
Patient Care
33%
Quality of Life
33%
Metabolite
33%
Gut Microbiota
33%
Insulin Resistance
33%
Insulin Sensitivity
33%
Primary Health Care
33%
Diet Induced Obesity
33%
Drug Therapy
33%
Stilbene
33%
Crohn's Disease
33%
Resveratrol
27%
Medication Error
24%
Comorbidity
20%
Endothelial Dysfunction
20%
Tumor Necrosis Factor
14%
Univariate Analysis
13%
Lipopolysaccharide
13%
Disease Duration
13%
Logistic Regression Analysis
11%
Odds Ratio
9%
Multivariate Analysis
6%
Inferential Statistics
6%
Pattern Recognition Receptor
6%
Blood Vessel Injury
6%
Protein-Ligand Interaction
6%
Nursing and Health Professions
Cross-Sectional Study
99%
Quality of Life
67%
Drug Therapy
42%
Primary Health Care
33%
Combination Therapy
33%
Chronic Disease
33%
Patient Care
33%
Acute Coronary Syndrome
33%
Antiinfective Agent
33%
Medication Error
28%
Medication Compliance
25%
Comorbidity
25%
Health Care Personnel
22%
Telemedicine
16%
Univariate Analysis
16%
Disease Duration
16%
Health Care
16%
Logistic Regression Analysis
8%
Multivariate Analysis
8%
Counseling
8%
Health Care Facility
8%
Inferential Statistics
8%
Percutaneous Coronary Intervention
7%
Quality of Life
7%
Literature Review
5%
Healthcare System
5%
Practice Guideline
5%
Amoxicillin
5%
Clavulanic Acid
5%
Antimicrobial Stewardship
5%
